Research by Network

Show research belonging to this network:

HVTN 703/HPTN 081 (AMP)

Current Study

A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in sub-Saharan Africa Sponsors: Division of AIDS (DAIDS) National Institute of Allergy and Infect …

HPTN

More about this study »

HPTN 082

Current Study

Evaluation of Daily Oral PrEP as a Primary Prevention Strategy for Young African Women: A Vanguard Study Sponsors: Division of AIDS (DAIDS) National Institute of Allergy and Infectious Diseases (NIAID) National Institute of Mental health (NIMH) Nationa …

HPTN

More about this study »

HPTN 084

Current Study

Study Title: A Phase 3 Double Blind Safety and Efficacy Study of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women. Protocol summary: HPTN 084 (The LIFE Study) is a study being done …

HPTN

More about this study »

HIVNET/HPTN 016A

Completed Study

Condom Promotion and Counseling Sponsor: US National Institutes of Health (NIH) Protocol Summary: The aim of the study was to evaluate the effectiveness of condom promotion and counseling messages on uptake of condoms as a means to prevent HIV transmis …

HPTN

More about this study »

HIVNET/HPTN 016A Substudy

Completed Study

Association of Sexually Transmitted Infections and HIV Among Women Attending the Condom Promotion and Counseling Study in Harare Sponsor: US National Institutes of Health (NIH) Protocol Summary: The aim of this substudy was to compare the prevalence of …

HPTN

More about this study »

HIVNET/HPTN 023

Completed Study

Safety and Trough Concentrations of Nevirapine Prophylaxis Given Daily, Twice Weekly, or Weekly in Breast-Feeding Infants from Birth to 6 Months Sponsor: US National Institutes of Health (NIH) Protocol Summary: HIVNET 023 was a phase I/II, open-label, …

HPTN

More about this study »

HPTN 039

Completed Study

A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Acyclovir for the Reduction of HIV Acquisition Among High Risk HSV-2 Seropositive, HIV Seronegative Individuals Sponsors: Division of AIDS, US National Institute of Allergy and Infectio …

HPTN

More about this study »

HPTN 043

Completed Study

A Phase III, Randomized, Controlled Trial of Community Mobilization, Mobile Testing, Same-Day Results, and Post-Testing Support for HIV in Sub-Saharan Africa and Thailand (Project Accept) Sponsor: US National Institute of Mental Health Protocol Summary …

HPTN

More about this study »

HPTN 052

Completed Study

A Randomized Trial to Evaluate the Effectiveness of Antiretroviral Therapy Plus HIV Primary Care versus HIV Primary Care Alone to Prevent the Sexual Transmission of HIV-1 in Serodiscordant Couples Sponsors: Division of AIDS, US National Institute of Al …

HPTN

More about this study »

HPTN 076

Completed Study

Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278 LA, for Pre Exposure Prophylaxis (PrEP) Sponsors: Division of AIDS, US National Institute of Allergy and Infectious Diseases (NIAID) US National Institutes of Health (NI …

HPTN

More about this study »